Panacea Innovation Ltd - 31 Dec 2024 SCHEDULE 13G/A Report for Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Venture Healthcare Fund II, L.P.
Security
Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol
AMLX
Shares outstanding
84,615,385 shares
Disclosed Ownership
2,200,000 shares
Ownership
2.6%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:30:03 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Panacea Innovation Ltd disclosed 2.6% ownership in Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX) on 31 Dec 2024."

Quick Takeaways

  • Panacea Innovation Ltd filed SCHEDULE 13G/A for Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (AMLX).
  • Disclosed ownership: 2.6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 2.6% 2,200,000 0 2,200,000 By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 2.6% 2,200,000 0 2,200,000 By: Panacea Innovation Limited, its sole owner, By: /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 2.6% 2,200,000 0 2,200,000 /s/ James Huang James Huang, Founding Managing Partner
James Huang 2.6% 2,200,000 0 2,200,000 /s/ James Huang James Huang

Sponsored